Compare FTRE & NMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTRE | NMZ |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | N/A |
| Metric | FTRE | NMZ |
|---|---|---|
| Price | $17.21 | $10.15 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $12.64 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 356.8K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,759,900,000.00 | N/A |
| Revenue This Year | $3.17 | N/A |
| Revenue Next Year | $0.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.88 | N/A |
| 52 Week Low | $3.97 | $8.26 |
| 52 Week High | $20.26 | $11.14 |
| Indicator | FTRE | NMZ |
|---|---|---|
| Relative Strength Index (RSI) | 70.75 | 27.89 |
| Support Level | $17.11 | $10.39 |
| Resistance Level | $18.04 | $10.60 |
| Average True Range (ATR) | 0.92 | 0.10 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 75.53 | 18.42 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.